Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Total Non-Current Liabilities: 2021

Historic Total Non-Current Liabilities for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $6.0 million.

  • Cardiol Therapeutics' Total Non-Current Liabilities rose 1549.53% to $49.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $49.7 million, marking a year-over-year increase of 1549.53%. This contributed to the annual value of $6.0 million for FY2021, which is N/A change from last year.
  • Cardiol Therapeutics' Total Non-Current Liabilities amounted to $6.0 million in FY2021.
  • Over the past 5 years, Cardiol Therapeutics' Total Non-Current Liabilities peaked at $6.0 million during FY2021, and registered a low of $6.0 million during FY2021.
  • Over the past 1 years, Cardiol Therapeutics' median Total Non-Current Liabilities value was $6.0 million (recorded in 2021), while the average stood at $6.0 million.